Viewing Study NCT00677612


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2026-02-28 @ 5:28 AM
Study NCT ID: NCT00677612
Status: TERMINATED
Last Update Posted: 2009-12-29
First Post: 2008-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
Sponsor: Tokyo University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CRC-A02-I, II
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Department of Surgery
Old Organization: The Institute of Medical Science, The University of Tokyo

Collaborators

Collaborators

Name Class View
None OTHER View